Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angioplasty, Balloon, Coronary | 39 | 2013 | 1725 | 1.670 |
Why?
|
Drug-Eluting Stents | 19 | 2015 | 681 | 0.930 |
Why?
|
Osteoarthritis, Knee | 10 | 2023 | 1234 | 0.820 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 14 | 2016 | 322 | 0.730 |
Why?
|
Stents | 20 | 2015 | 3179 | 0.570 |
Why?
|
Registries | 38 | 2016 | 8225 | 0.490 |
Why?
|
Arthroplasty, Replacement, Knee | 7 | 2023 | 1393 | 0.470 |
Why?
|
Obesity, Morbid | 6 | 2023 | 1277 | 0.420 |
Why?
|
Coronary Artery Disease | 20 | 2016 | 6403 | 0.420 |
Why?
|
Bariatric Surgery | 6 | 2021 | 992 | 0.380 |
Why?
|
Coronary Disease | 14 | 2012 | 5914 | 0.380 |
Why?
|
Gastric Bypass | 4 | 2023 | 818 | 0.360 |
Why?
|
Pain Measurement | 5 | 2024 | 3551 | 0.290 |
Why?
|
Myocardial Infarction | 25 | 2016 | 11461 | 0.290 |
Why?
|
Exercise Therapy | 3 | 2019 | 929 | 0.280 |
Why?
|
Myocardial Revascularization | 6 | 2012 | 790 | 0.280 |
Why?
|
Menopause | 7 | 2016 | 1646 | 0.260 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2009 | 2155 | 0.250 |
Why?
|
Carotid Artery Diseases | 3 | 2014 | 877 | 0.240 |
Why?
|
Catastrophization | 2 | 2020 | 348 | 0.230 |
Why?
|
Coronary Vessels | 5 | 2014 | 3096 | 0.220 |
Why?
|
Spondylarthritis | 1 | 2024 | 61 | 0.210 |
Why?
|
Spondylitis, Ankylosing | 1 | 2024 | 155 | 0.200 |
Why?
|
Diabetes Complications | 6 | 2021 | 1315 | 0.200 |
Why?
|
Women's Health | 4 | 2016 | 2065 | 0.190 |
Why?
|
Vasomotor System | 2 | 2012 | 207 | 0.190 |
Why?
|
Hot Flashes | 3 | 2012 | 330 | 0.180 |
Why?
|
Coronary Restenosis | 7 | 2013 | 396 | 0.180 |
Why?
|
Preoperative Period | 3 | 2020 | 551 | 0.170 |
Why?
|
Uveitis | 1 | 2024 | 395 | 0.170 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2019 | 45 | 0.170 |
Why?
|
Metals | 6 | 2015 | 719 | 0.170 |
Why?
|
Diabetes Mellitus | 8 | 2021 | 5841 | 0.170 |
Why?
|
Treatment Outcome | 41 | 2024 | 64685 | 0.160 |
Why?
|
Middle Aged | 72 | 2021 | 220921 | 0.160 |
Why?
|
Laparoscopy | 3 | 2022 | 2036 | 0.160 |
Why?
|
Frail Elderly | 1 | 2024 | 765 | 0.160 |
Why?
|
Knee Injuries | 1 | 2023 | 488 | 0.160 |
Why?
|
Coronary Stenosis | 3 | 2011 | 794 | 0.160 |
Why?
|
Clubfoot | 1 | 2019 | 87 | 0.150 |
Why?
|
Coronary Angiography | 13 | 2014 | 4471 | 0.150 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 598 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2004 | 735 | 0.150 |
Why?
|
Aged | 58 | 2024 | 169310 | 0.140 |
Why?
|
Female | 86 | 2024 | 392705 | 0.140 |
Why?
|
Geriatric Assessment | 1 | 2024 | 1410 | 0.140 |
Why?
|
United States | 39 | 2021 | 72340 | 0.130 |
Why?
|
Weight Loss | 4 | 2023 | 2684 | 0.130 |
Why?
|
Hip Fractures | 1 | 2024 | 988 | 0.130 |
Why?
|
Follicle Stimulating Hormone | 2 | 2015 | 726 | 0.130 |
Why?
|
Risk Factors | 33 | 2024 | 74213 | 0.130 |
Why?
|
Disability Evaluation | 2 | 2024 | 1836 | 0.130 |
Why?
|
Male | 74 | 2024 | 360846 | 0.120 |
Why?
|
Renal Insufficiency | 2 | 2016 | 809 | 0.120 |
Why?
|
Carotid Arteries | 2 | 2014 | 941 | 0.120 |
Why?
|
Follow-Up Studies | 22 | 2021 | 39106 | 0.120 |
Why?
|
Gastroplasty | 2 | 2016 | 157 | 0.120 |
Why?
|
Humans | 97 | 2024 | 761596 | 0.120 |
Why?
|
Orthopedic Procedures | 1 | 2024 | 1265 | 0.110 |
Why?
|
Pain, Postoperative | 2 | 2024 | 1740 | 0.110 |
Why?
|
Angina, Unstable | 2 | 2009 | 888 | 0.110 |
Why?
|
Prescriptions | 1 | 2016 | 386 | 0.110 |
Why?
|
Osteoarthritis | 1 | 2021 | 1063 | 0.110 |
Why?
|
Hospital Mortality | 13 | 2012 | 5293 | 0.110 |
Why?
|
Aorta | 1 | 2001 | 2041 | 0.110 |
Why?
|
Cardiovascular Agents | 3 | 2016 | 840 | 0.110 |
Why?
|
Compression Bandages | 1 | 2012 | 14 | 0.100 |
Why?
|
Hemorrhage | 2 | 2016 | 3424 | 0.100 |
Why?
|
Prosthesis Design | 7 | 2014 | 2115 | 0.100 |
Why?
|
Coronary Circulation | 2 | 2010 | 1569 | 0.100 |
Why?
|
Proportional Hazards Models | 13 | 2013 | 12463 | 0.100 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1588 | 0.100 |
Why?
|
Retreatment | 5 | 2011 | 598 | 0.100 |
Why?
|
Prospective Studies | 21 | 2020 | 54423 | 0.090 |
Why?
|
Arthralgia | 1 | 2015 | 461 | 0.090 |
Why?
|
Vascular Diseases | 2 | 2013 | 1161 | 0.090 |
Why?
|
Coronary Aneurysm | 1 | 2013 | 232 | 0.090 |
Why?
|
Blood Flow Velocity | 3 | 2005 | 1371 | 0.090 |
Why?
|
Binge-Eating Disorder | 1 | 2012 | 147 | 0.090 |
Why?
|
Time Factors | 19 | 2016 | 39969 | 0.090 |
Why?
|
Coronary Artery Bypass | 9 | 2011 | 2188 | 0.090 |
Why?
|
Academies and Institutes | 1 | 2012 | 318 | 0.090 |
Why?
|
Drug Utilization | 1 | 2016 | 1188 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 3124 | 0.080 |
Why?
|
Chi-Square Distribution | 6 | 2012 | 3415 | 0.080 |
Why?
|
Age Factors | 11 | 2024 | 18399 | 0.080 |
Why?
|
Patient Compliance | 2 | 2018 | 2690 | 0.080 |
Why?
|
Exercise Tolerance | 1 | 2014 | 836 | 0.080 |
Why?
|
Telemetry | 1 | 2010 | 199 | 0.080 |
Why?
|
beta 2-Glycoprotein I | 1 | 2009 | 28 | 0.080 |
Why?
|
Comorbidity | 9 | 2018 | 10508 | 0.080 |
Why?
|
Pain | 3 | 2023 | 5073 | 0.080 |
Why?
|
Hemostasis | 1 | 2011 | 467 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2016 | 631 | 0.080 |
Why?
|
Diabetic Angiopathies | 2 | 2011 | 803 | 0.080 |
Why?
|
Patient Discharge | 2 | 2016 | 3443 | 0.080 |
Why?
|
Motor Activity | 1 | 2018 | 2715 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2016 | 2751 | 0.080 |
Why?
|
Obesity | 5 | 2023 | 12947 | 0.070 |
Why?
|
After-Hours Care | 1 | 2008 | 102 | 0.070 |
Why?
|
Gastrectomy | 2 | 2023 | 672 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 488 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3688 | 0.070 |
Why?
|
Sex Factors | 7 | 2011 | 10554 | 0.070 |
Why?
|
Tunica Intima | 2 | 2013 | 459 | 0.070 |
Why?
|
Severity of Illness Index | 9 | 2020 | 15843 | 0.070 |
Why?
|
Lipoproteins | 1 | 2012 | 881 | 0.070 |
Why?
|
Arteriosclerosis | 2 | 2004 | 1055 | 0.070 |
Why?
|
Survival Rate | 9 | 2013 | 12723 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2421 | 0.070 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2010 | 396 | 0.070 |
Why?
|
Sweating | 3 | 2012 | 155 | 0.070 |
Why?
|
Computer Systems | 1 | 2008 | 470 | 0.070 |
Why?
|
Kidney Failure, Chronic | 2 | 2011 | 2472 | 0.070 |
Why?
|
Arterial Occlusive Diseases | 1 | 2011 | 748 | 0.070 |
Why?
|
Iliac Aneurysm | 1 | 2006 | 37 | 0.070 |
Why?
|
Insulin | 3 | 2012 | 6597 | 0.070 |
Why?
|
Risk Assessment | 10 | 2016 | 23996 | 0.060 |
Why?
|
Blood Transfusion | 2 | 2016 | 1301 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 6 | 2013 | 6484 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2006 | 1428 | 0.060 |
Why?
|
Osteoporotic Fractures | 1 | 2010 | 411 | 0.060 |
Why?
|
Monitoring, Ambulatory | 1 | 2008 | 354 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 555 | 0.060 |
Why?
|
Cause of Death | 3 | 2011 | 3683 | 0.060 |
Why?
|
Telephone | 1 | 2008 | 627 | 0.060 |
Why?
|
Heart Failure | 4 | 2011 | 11671 | 0.060 |
Why?
|
Creatinine | 2 | 2007 | 1899 | 0.060 |
Why?
|
Patient Readmission | 2 | 2024 | 3271 | 0.060 |
Why?
|
Thrombosis | 3 | 2013 | 2942 | 0.060 |
Why?
|
Recurrence | 5 | 2019 | 8466 | 0.060 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2005 | 198 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2644 | 0.060 |
Why?
|
Longitudinal Studies | 6 | 2021 | 14608 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4244 | 0.060 |
Why?
|
Collateral Circulation | 1 | 2005 | 294 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2461 | 0.060 |
Why?
|
Aorta, Abdominal | 1 | 2007 | 625 | 0.060 |
Why?
|
Adult | 19 | 2021 | 221210 | 0.060 |
Why?
|
Fibrinogen | 2 | 2011 | 888 | 0.050 |
Why?
|
Retrospective Studies | 16 | 2024 | 80647 | 0.050 |
Why?
|
Embolism | 1 | 2007 | 399 | 0.050 |
Why?
|
Remission Induction | 2 | 2021 | 2397 | 0.050 |
Why?
|
Pulsatile Flow | 1 | 2004 | 321 | 0.050 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 1555 | 0.050 |
Why?
|
Angina Pectoris | 1 | 2006 | 959 | 0.050 |
Why?
|
Carotid Artery, Internal | 1 | 2005 | 445 | 0.050 |
Why?
|
Hematoma | 1 | 2007 | 767 | 0.050 |
Why?
|
Quality of Life | 4 | 2019 | 13367 | 0.050 |
Why?
|
Calcinosis | 1 | 2011 | 1469 | 0.050 |
Why?
|
Stroke Volume | 4 | 2011 | 5496 | 0.050 |
Why?
|
Cohort Studies | 9 | 2024 | 41495 | 0.050 |
Why?
|
Carotid Stenosis | 2 | 2009 | 860 | 0.050 |
Why?
|
Graft Occlusion, Vascular | 1 | 2005 | 537 | 0.050 |
Why?
|
Blood Glucose | 3 | 2012 | 6391 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5890 | 0.050 |
Why?
|
Myocardial Ischemia | 2 | 2009 | 2113 | 0.050 |
Why?
|
Mental Health | 1 | 2015 | 3250 | 0.050 |
Why?
|
Minority Groups | 1 | 2008 | 1203 | 0.050 |
Why?
|
Linear Models | 3 | 2019 | 5872 | 0.050 |
Why?
|
Immunosuppressive Agents | 3 | 2012 | 4176 | 0.050 |
Why?
|
Estradiol | 3 | 2012 | 1937 | 0.040 |
Why?
|
Medical Errors | 1 | 2008 | 1263 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2872 | 0.040 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58984 | 0.040 |
Why?
|
Postoperative Period | 2 | 2020 | 1814 | 0.040 |
Why?
|
Blood Vessel Prosthesis | 1 | 2005 | 951 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 532 | 0.040 |
Why?
|
Inpatients | 2 | 2009 | 2548 | 0.040 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2850 | 0.040 |
Why?
|
Back Pain | 1 | 2024 | 545 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2003 | 600 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5493 | 0.040 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 2917 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 463 | 0.040 |
Why?
|
Postoperative Complications | 6 | 2013 | 15633 | 0.040 |
Why?
|
Incidence | 7 | 2013 | 21355 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2015 | 3407 | 0.040 |
Why?
|
Odds Ratio | 5 | 2016 | 9647 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2013 | 3233 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2012 | 1866 | 0.040 |
Why?
|
Musculoskeletal Manipulations | 1 | 2018 | 24 | 0.040 |
Why?
|
Elasticity | 1 | 2001 | 655 | 0.040 |
Why?
|
Tenotomy | 1 | 2019 | 55 | 0.040 |
Why?
|
Hypoglycemic Agents | 2 | 2009 | 3085 | 0.040 |
Why?
|
Benchmarking | 1 | 2005 | 1045 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2012 | 3964 | 0.040 |
Why?
|
Braces | 1 | 2019 | 138 | 0.040 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2011 | 1875 | 0.040 |
Why?
|
Serum Albumin | 1 | 2001 | 672 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2018 | 1702 | 0.040 |
Why?
|
Casts, Surgical | 1 | 2019 | 183 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5790 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 981 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2576 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2007 | 1228 | 0.030 |
Why?
|
Haiti | 1 | 2019 | 550 | 0.030 |
Why?
|
Coronary Thrombosis | 2 | 2011 | 440 | 0.030 |
Why?
|
Kidney | 2 | 2016 | 7048 | 0.030 |
Why?
|
Femoral Artery | 1 | 2001 | 826 | 0.030 |
Why?
|
Anticoagulants | 1 | 2012 | 4812 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8710 | 0.030 |
Why?
|
Czech Republic | 1 | 2016 | 74 | 0.030 |
Why?
|
Resistance Training | 1 | 2018 | 193 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3204 | 0.030 |
Why?
|
Angioplasty | 2 | 2010 | 355 | 0.030 |
Why?
|
Canada | 2 | 2016 | 2122 | 0.030 |
Why?
|
Efficiency | 1 | 2019 | 476 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2759 | 0.030 |
Why?
|
Length of Stay | 4 | 2012 | 6426 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2016 | 504 | 0.030 |
Why?
|
Life Tables | 2 | 2006 | 364 | 0.030 |
Why?
|
Glomerular Filtration Rate | 2 | 2016 | 2178 | 0.030 |
Why?
|
Smoking | 3 | 2011 | 9053 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2011 | 3826 | 0.030 |
Why?
|
Prognosis | 5 | 2018 | 29629 | 0.030 |
Why?
|
C-Peptide | 1 | 2016 | 440 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2009 | 5440 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3246 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 1241 | 0.030 |
Why?
|
Contrast Media | 1 | 2007 | 5307 | 0.030 |
Why?
|
Electrocardiography | 1 | 2007 | 6377 | 0.030 |
Why?
|
Guideline Adherence | 2 | 2018 | 2220 | 0.030 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15266 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7859 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10766 | 0.030 |
Why?
|
Recovery of Function | 1 | 2024 | 2979 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2319 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2010 | 1516 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2011 | 12059 | 0.030 |
Why?
|
Hematopoietic Cell Growth Factors | 1 | 1993 | 98 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 8527 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4793 | 0.030 |
Why?
|
Tunica Media | 1 | 2013 | 112 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2010 | 15936 | 0.030 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2012 | 25 | 0.030 |
Why?
|
Radiation-Protective Agents | 1 | 1993 | 88 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2016 | 1796 | 0.030 |
Why?
|
Age Distribution | 2 | 2011 | 2879 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10212 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 12149 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10774 | 0.020 |
Why?
|
Regression Analysis | 1 | 2001 | 6345 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2691 | 0.020 |
Why?
|
Body Mass Index | 3 | 2018 | 12953 | 0.020 |
Why?
|
Factor VII | 1 | 2011 | 139 | 0.020 |
Why?
|
Logistic Models | 3 | 2016 | 13255 | 0.020 |
Why?
|
Reward | 1 | 2018 | 971 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6312 | 0.020 |
Why?
|
Atherectomy, Coronary | 1 | 2011 | 137 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2010 | 17904 | 0.020 |
Why?
|
Hospitalization | 5 | 2009 | 10721 | 0.020 |
Why?
|
Angiography | 2 | 2006 | 1595 | 0.020 |
Why?
|
Risk | 3 | 2011 | 9610 | 0.020 |
Why?
|
Hyperplasia | 1 | 2013 | 1152 | 0.020 |
Why?
|
Aspirin | 2 | 2012 | 3133 | 0.020 |
Why?
|
Arthroscopy | 1 | 2016 | 969 | 0.020 |
Why?
|
Insulin, Long-Acting | 1 | 2009 | 58 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1993 | 1248 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 527 | 0.020 |
Why?
|
Models, Statistical | 1 | 2003 | 5079 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 621 | 0.020 |
Why?
|
Research Design | 2 | 2019 | 6180 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2009 | 293 | 0.020 |
Why?
|
Patient Care Team | 1 | 2019 | 2521 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2012 | 638 | 0.020 |
Why?
|
Nitrates | 1 | 2009 | 263 | 0.020 |
Why?
|
Motivation | 1 | 2018 | 2006 | 0.020 |
Why?
|
Ticlopidine | 1 | 2012 | 730 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7391 | 0.020 |
Why?
|
Preoperative Care | 1 | 2016 | 2242 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2010 | 516 | 0.020 |
Why?
|
Product Labeling | 1 | 2008 | 76 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 14033 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 888 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15502 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1670 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2009 | 694 | 0.020 |
Why?
|
Observation | 1 | 2008 | 310 | 0.020 |
Why?
|
North America | 1 | 2009 | 1276 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1164 | 0.020 |
Why?
|
Mood Disorders | 1 | 2012 | 1127 | 0.020 |
Why?
|
Sirolimus | 1 | 2012 | 1533 | 0.020 |
Why?
|
Hospital Records | 1 | 2005 | 93 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2016 | 2639 | 0.020 |
Why?
|
Lupus Nephritis | 1 | 2009 | 317 | 0.020 |
Why?
|
Paclitaxel | 1 | 2012 | 1732 | 0.020 |
Why?
|
Prevalence | 2 | 2013 | 15733 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2009 | 609 | 0.020 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2008 | 495 | 0.020 |
Why?
|
Iliac Artery | 1 | 2006 | 343 | 0.010 |
Why?
|
Coronary Occlusion | 1 | 2007 | 304 | 0.010 |
Why?
|
Survival Analysis | 2 | 2008 | 10090 | 0.010 |
Why?
|
Affect | 1 | 2012 | 1486 | 0.010 |
Why?
|
Polysomnography | 1 | 2011 | 1848 | 0.010 |
Why?
|
Cost of Illness | 1 | 2013 | 1937 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9327 | 0.010 |
Why?
|
Hip Joint | 1 | 2010 | 1014 | 0.010 |
Why?
|
Area Under Curve | 1 | 2007 | 1638 | 0.010 |
Why?
|
Propensity Score | 1 | 2011 | 1913 | 0.010 |
Why?
|
Vascular Patency | 1 | 2006 | 911 | 0.010 |
Why?
|
Reproducibility of Results | 3 | 2007 | 20100 | 0.010 |
Why?
|
Primary Health Care | 2 | 2010 | 4687 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1303 | 0.010 |
Why?
|
Workload | 1 | 2008 | 844 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2713 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7828 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2010 | 1902 | 0.010 |
Why?
|
Collagen | 1 | 2010 | 2638 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3420 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3606 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2005 | 793 | 0.010 |
Why?
|
Home Care Services | 1 | 2008 | 648 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2009 | 883 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2007 | 709 | 0.010 |
Why?
|
Fatigue | 1 | 2008 | 1552 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5247 | 0.010 |
Why?
|
Homeostasis | 1 | 2012 | 3323 | 0.010 |
Why?
|
Brachytherapy | 1 | 2008 | 1223 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2735 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2720 | 0.010 |
Why?
|
Blood Pressure | 2 | 2011 | 8481 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2010 | 1879 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 577 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2009 | 1376 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4111 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 2007 | 1474 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6056 | 0.010 |
Why?
|
Disease Management | 1 | 2010 | 2508 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2005 | 1204 | 0.010 |
Why?
|
Incidental Findings | 1 | 2004 | 697 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6864 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2567 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26202 | 0.010 |
Why?
|
Equipment Design | 1 | 2007 | 3511 | 0.010 |
Why?
|
Echocardiography | 1 | 2011 | 4989 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 2280 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2007 | 2084 | 0.010 |
Why?
|
Bone Density | 1 | 2010 | 3551 | 0.010 |
Why?
|
Medical Records | 1 | 2002 | 1408 | 0.010 |
Why?
|
Lung Diseases | 1 | 2007 | 1909 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2358 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36193 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2006 | 1418 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2007 | 2091 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42232 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1993 | 9177 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3537 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2226 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3889 | 0.010 |
Why?
|
Reoperation | 1 | 2005 | 4303 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2003 | 2064 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4016 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2007 | 20568 | 0.010 |
Why?
|
Stem Cell Factor | 1 | 1993 | 195 | 0.010 |
Why?
|
Medicare | 1 | 2010 | 6770 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1993 | 262 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9319 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1993 | 882 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 22176 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16592 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1762 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14665 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1999 | 1881 | 0.010 |
Why?
|
Cholesterol | 1 | 1999 | 2905 | 0.010 |
Why?
|
Hypertension | 1 | 2008 | 8540 | 0.000 |
Why?
|
Disease Progression | 1 | 2004 | 13510 | 0.000 |
Why?
|
Lipopolysaccharides | 1 | 1993 | 2206 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1993 | 6534 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1993 | 4352 | 0.000 |
Why?
|
Neoplasms | 1 | 2009 | 22173 | 0.000 |
Why?
|
Mice | 1 | 1993 | 81539 | 0.000 |
Why?
|
Animals | 1 | 1993 | 168475 | 0.000 |
Why?
|